OBESITY References

1.            Brooks PM. The burden of musculoskeletal disease--a global perspective. Clin Rheumatol 25: 778-781, 2006.

2.            Chasens ER, Weaver TE, and Umlauf MG. Insulin resistance and obstructive sleep apnea: is increased sympathetic stimulation the link? Biol Res Nurs 5: 87-96, 2003.

3.            Chervin RD, Ruzicka DL, Giordani BJ, Weatherly RA, Dillon JE, Hodges EK, Marcus CL, and Guire KE. Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics 117: e769-778, 2006.

4.            Christensen R, Bartels EM, Astrup A, and Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 66: 433-439, 2007.

5.            Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, and Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25: 735-741, 2004.

6.            Devereux RB, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Rodeheffer RJ, Cowan LD, and Howard BV. A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study. Am Heart J 141: 439-446, 2001.

7.            Drummond S. Obesity: a diet that is acceptable is more likely to succeed. J Fam Health Care 17: 219-221, 2007.

8.            Dubnov G, Brzezinski A, and Berry EM. Weight control and the management of obesity after menopause: the role of physical activity. Maturitas 44: 89-101, 2003.

9.            Fogelholm M, Kronholm E, Kukkonen-Harjula K, Partonen T, Partinen M, and Harma M. Sleep-related disturbances and physical chronic inactivity are independently associated with obesity in adults. Int J Obes (Lond) 31: 1713-1721, 2007.

10.            Gagliardi L, and Wittert G. Management of obesity in patients with type 2 diabetes mellitus. Curr Diabetes Rev 3: 95-101, 2007.

11.       Gami AS, Caples SM, and Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32: 869-894, 2003.

12.       Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T, and Somers VK. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49: 565-571, 2007.

13.            Gilbert PA, and Khokhar S. Changing dietary habits of ethnic groups in Europe and implications for health. Nutr Rev 66: 203-215, 2008.

14.            Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, and Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 49: 535-541, 2007.

15.            Gunnarsson OT, and Judge JO. Exercise at midlife: how and why to prescribe it for sedentary patients. Geriatrics 52: 71-72, 77-80; quiz 81, 1997.

16.            Harsch IA, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, and Ficker JH. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22: 251-257, 2003.

17.            Harsch IA, Schahin SP, Bruckner K, Radespiel-Troger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T, and Ficker JH. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 71: 252-259, 2004.

18.            Hastings PC, Vazir A, O'Driscoll DM, Morrell MJ, and Simonds AK. Symptom burden of sleep-disordered breathing in mild-to-moderate congestive heart failure patients. Eur Respir J 27: 748-755, 2006.

19.       Hill CM, Hogan AM, Onugha N, Harrison D, Cooper S, McGrigor VJ, Datta A, and Kirkham FJ. Increased cerebral blood flow velocity in children with mild sleep-disordered breathing: a possible association with abnormal neuropsychological function. Pediatrics 118: e1100-1108, 2006.

20.            Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 115 Suppl 8A: 111S-115S, 2003.

21.            Hudgel DW. Mechanisms of obstructive sleep apnea. Chest 101: 541-549, 1992.

22.            James WP. The fundamental drivers of the obesity epidemic. Obes Rev 9 Suppl 1: 6-13, 2008.

23.       Klok MD, Jakobsdottir S, and Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 8: 21-34, 2007.

24.            Knutson KL, Spiegel K, Penev P, and Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 11: 163-178, 2007.

25.            Lankford DA, Proctor CD, and Richard R. Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss. Obes Surg 15: 336-341, 2005.

26.       Leslie WS, Hankey CR, and Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM 100: 395-404, 2007.

27.       LeVay AJ, and Kveton JF. Relationship between obesity, obstructive sleep apnea, and spontaneous cerebrospinal fluid otorrhea. Laryngoscope 118: 275-278, 2008.

28.            Mahajan A, Verma S, and Tandon V. Osteoarthritis. J Assoc Physicians India 53: 634-641, 2005.

29.            McNab AA. The eye and sleep apnea. Sleep Med Rev 11: 269-276, 2007.

30.            Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, and Marchioli R. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 370: 667-675, 2007.

31.            Narkiewicz K, and Somers VK. Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177: 385-390, 2003.

32.       Ness-Abramof R, and Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 41: 547-555, 2005.

33.       Patel C, Wyne KL, and McGuire DK. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diab Vasc Dis Res 2: 61-66, 2005.

34.       Penev PD. Sleep deprivation and energy metabolism: to sleep, perchance to eat? Curr Opin Endocrinol Diabetes Obes 14: 374-381, 2007.

35.            Piechota G, Malkiewicz J, and Karwat ID. [Obesity as a cause and result of disability]. Przegl Epidemiol 59: 155-161, 2005.

36.       Pijl H, and Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.

37.       Pillar G, and Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31 Suppl 2: S303-309, 2008.

38.            Popovic V, and Duntas LH. Brain somatic cross-talk: ghrelin, leptin and ultimate challengers of obesity. Nutr Neurosci 8: 1-5, 2005.

39.            Punjabi NM, and Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99: 1998-2007, 2005.

40.            Roemmich JN, Barkley JE, D'Andrea L, Nikova M, Rogol AD, Carskadon MA, and Suratt PM. Increases in overweight after adenotonsillectomy in overweight children with obstructive sleep-disordered breathing are associated with decreases in motor activity and hyperactivity. Pediatrics 117: e200-208, 2006.

41.            Saaresranta T, and Polo O. Does leptin link sleep loss and breathing disturbances with major public diseases? Ann Med 36: 172-183, 2004.

42.            Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, and Ohi M. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 57: 429-434, 2002.

43.            Spiegel K, Knutson K, Leproult R, Tasali E, and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99: 2008-2019, 2005.

44.            Steinberg GR. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle 6: 888-894, 2007.

45.       Strohl KP. Diabetes and sleep apnea. Sleep 19: S225-228, 1996.

46.       Strohl KP, Boehm KD, Denko CW, Novak RD, and Decker MJ. Biochemical morbidity in sleep apnea. Ear Nose Throat J 72: 34, 39-41, 1993.

47.            Trenell MI, Marshall NS, and Rogers NL. Sleep and metabolic control: waking to a problem? Clin Exp Pharmacol Physiol 34: 1-9, 2007.

48.       Varela JE, Hinojosa MW, and Nguyen NT. Resolution of obstructive sleep apnea after laparoscopic gastric bypass. Obes Surg 17: 1279-1282, 2007.

49.            Varela-Moreiras G. Controlling obesity: what should be changed? Int J Vitam Nutr Res 76: 262-268, 2006.

50.            Vgontzas AN, Bixler EO, and Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254: 32-44, 2003.

51.            Wearing SC, Hennig EM, Byrne NM, Steele JR, and Hills AP. Musculoskeletal disorders associated with obesity: a biomechanical perspective. Obes Rev 7: 239-250, 2006.

52.            Williams DL, and Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr 135: 1320-1325, 2005.

53.            Wofford MR, and King DS. Relationship between antihypertensive drugs and metabolic syndrome. Metab Syndr Relat Disord 2: 308-314, 2004.

54.       Yun AJ, Lee PY, and Bazar KA. Autonomic dysregulation as a basis of cardiovascular, endocrine, and inflammatory disturbances associated with obstructive sleep apnea and other conditions of chronic hypoxia, hypercapnia, and acidosis. Med Hypotheses 62: 852-856, 2004.